Tue Aug 30, 2011 7:02am EDT
* Co says may need to do additional trials
* FDA raises issues related to manufacturing, safety
Aug 30 (Reuters) - NuPathe Inc said the U.S. health regulator rejected its experimental migraine patch and the company may need to conduct additional trials to address the issues raised by regulators.
In a complete response letter to the company, the U.S. Food and Drug Administration raised questions related to the chemistry, manufacturing and safety of the treatment, known as Zelrix, the company said in a statement.
NuPathe believes it has, or shortly will have, sufficient data to address the issues and may conduct additional early-stage and/or non-clinical studies to address other questions.
The company will also request a meeting with the FDA to discuss the letter and its approach to resolve the issues.
Migraine is a neurological disorder that affects about 30 million adults in the United States, NuPathe said.
Shares of the company closed at $4.05 on Monday on Nasdaq. (Reporting by Esha Dey in Bangalore; Editing by Roshni Menon)
Recent PATH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 10:16:28 PM
- UiPath State of the Automation Professional Report Highlights 2024 as the Year of AI Integration • Business Wire • 09/16/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:24:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 08:17:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 08:20:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/06/2024 09:13:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 08:14:27 PM
- Broadcom Down 10% Post-Earnings, UiPath Up 8%; Qualcomm Eyes Intel Assets; Salesforce Acquires Own Company • IH Market News • 09/06/2024 11:59:00 AM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 09/05/2024 11:19:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:17:42 PM
- UiPath Reports Second Quarter Fiscal 2025 Financial Results • Business Wire • 09/05/2024 08:10:00 PM
- UiPath Chief Financial Officer Ashim Gupta Takes on Expanded Role as Chief Operating Officer • Business Wire • 09/05/2024 08:10:00 PM
- UiPath Appoints S. Somasegar to its Board of Directors • Business Wire • 09/05/2024 08:10:00 PM
- U.S. Index Futures Steady Amid Labor Data Anticipation; Oil Prices Rise • IH Market News • 09/05/2024 10:13:05 AM
- UiPath Unveils Partner Sponsors for FORWARD, the Largest Global Event for Automation and AI Practitioners • Business Wire • 09/04/2024 02:30:00 PM
- UiPath to Participate in the Piper Sandler Growth Frontiers Conference • Business Wire • 09/03/2024 08:10:00 PM
- UiPath Named a Leader in Everest Group Digital Interaction Intelligence Products PEAK Matrix® Assessment 2024 • Business Wire • 08/26/2024 12:33:00 PM
- UiPath, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 19, 2024 to Discuss Your Rights - PATH • PR Newswire (US) • 08/19/2024 09:45:00 AM
- UiPath, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 19, 2024 to Discuss Your Rights - PATH • PR Newswire (US) • 08/15/2024 09:45:00 AM
- UiPath Recognized as a Leader in the 2024 Gartner Magic Quadrant for Robotic Process Automation • Business Wire • 08/12/2024 03:56:00 PM
- Lost Money on UiPath, Inc.(PATH)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 08/12/2024 09:30:00 AM
- UiPath Announces Second Quarter Fiscal 2025 Financial Results Conference Call • Business Wire • 08/08/2024 08:10:00 PM
- The Gross Law Firm Reminds UiPath Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 19, 2024 - PATH • PR Newswire (US) • 08/08/2024 09:45:00 AM
- UiPath Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PATH • PR Newswire (US) • 08/06/2024 02:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM